For the year ending 2025-12-31, CLDX has $582,983K in assets. $55,818K in debts. $28,871K in cash and cash equivalents.
| Balance Sheets | 2025-12-31 | |||
|---|---|---|---|---|
| Cash and cash equivalents | 28,871 | |||
| Maturing in one year or less-USTreasury And Government | 151,749 | |||
| Maturing after one year through three years-USTreasury And Government | 42,485 | |||
| Maturing in one year or less-Corporate Debt Securities | 257,437 | |||
| Maturing after one year through three years-Corporate Debt Securities | 38,031 | |||
| Marketable securities | 489,702 | |||
| Accounts and other receivables | 2,015 | |||
| Prepaid and other current assets | 14,076 | |||
| Total current assets | 534,664 | |||
| Property and equipment, net | 5,334 | |||
| Operating lease right-of-use assets, net | 2,437 | |||
| Intangible assets | 27,190 | |||
| Other assets | 13,358 | |||
| Total assets | 582,983 | |||
| Accounts payable | 1,180 | |||
| Accrued expenses | 47,029 | |||
| Current portion of operating lease liabilities | 1,552 | |||
| Current portion of long-term liabilities | 1,230 | |||
| Total current liabilities | 50,991 | |||
| Long-term portion of operating lease liabilities | 784 | |||
| Other long-term liabilities | 4,043 | |||
| Total liabilities | 55,818 | |||
| Common stock, .001 par value 297,000,000 shares authorized 66,549,442 and 66,374,549 shares issued and outstanding at december 31, 2025 and 2024, respectively | 67 | |||
| Additional paid-in capital | 2,337,453 | |||
| Accumulated other comprehensive income | 3,626 | |||
| Accumulated deficit | -1,813,981 | |||
| Total stockholders' equity | 527,165 | |||
| Total liabilities and stockholders' equity | 582,983 | |||
Celldex Therapeutics, Inc. (CLDX)
Celldex Therapeutics, Inc. (CLDX)